Mesenchymal Stromal Cell Therapy Improves Refractory Perianal Fistula in Crohn’s Disease: Case Series Clinical Interventional Study

OBJECTIVE: Perianal fistulas in Crohn’s disease (CD) are the main challenges in inflammatory bowel diseases (IBDs). Some of the fistulas are refractory to any therapeutic strategy. The aim of this study was to evaluate the therapeutic effects of mesenchymal stromal cells (MSCs) as a novel promising...

Descripción completa

Detalles Bibliográficos
Autores principales: Vosough, Massoud, Nikfam, Sepideh, Torabi, Shukoofeh, Sadri, Bahareh, Ahmadi Amoli, Hadi, Basi, Ali, Niknejadi, Maryam, Hossein-Khannazer, Nikoo, Hosseini, Seyedeh-Esmat, Mardpour, Soura, Azimian, Vajiheh, Jaroughi, Neda, Aghdami, Nasser, Amirzehni, Hamid Reza, Anushirvani, Amir, Malekzadeh, Reza, Baharvand, Hossein, Mohamadnejad, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royan Institute 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918267/
https://www.ncbi.nlm.nih.gov/pubmed/35279961
http://dx.doi.org/10.22074/cellj.2022.7981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918267/
https://www.ncbi.nlm.nih.gov/pubmed/35279961
http://dx.doi.org/10.22074/cellj.2022.7981

Ejemplares similares